🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide ◆ The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany ◆ Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact ◆ The Pharmacist's Role: How Community Pharmacies in Ireland and the UK Are Adapting as Patients Bypass High-Street Stores for Direct Delivery ◆ GLP-1 Therapeutics and Clinical Research Updates: Brain Reward Mapping, Oral Small Molecules, and Triple-Agonist Horizons ◆ Rinn Pharma & Biopharma Joins NordicPharmaTrain Network to Accelerate European Research & Advanced Manufacturing ◆ Markets Surge as August Opens: $400B Big Pharma Merger Speculation & AstraZeneca Deal Talks Grab Global Headlines ◆ Trump’s September Visit to Ireland: Agenda, Economic Policy Evaluation & U.S.-Irish Trade Implications ◆ Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide ◆ The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany ◆ Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact ◆ The Pharmacist's Role: How Community Pharmacies in Ireland and the UK Are Adapting as Patients Bypass High-Street Stores for Direct Delivery ◆ GLP-1 Therapeutics and Clinical Research Updates: Brain Reward Mapping, Oral Small Molecules, and Triple-Agonist Horizons ◆ Rinn Pharma & Biopharma Joins NordicPharmaTrain Network to Accelerate European Research & Advanced Manufacturing ◆ Markets Surge as August Opens: $400B Big Pharma Merger Speculation & AstraZeneca Deal Talks Grab Global Headlines ◆ Trump’s September Visit to Ireland: Agenda, Economic Policy Evaluation & U.S.-Irish Trade Implications ◆
Updated 04 Jul 2026 · HPRA open data

Ascendis Pharma Endocrinology Division A/S — Licensed Medicines

9 medicines held by Ascendis Pharma Endocrinology Division A/S on the Irish market, from the HPRA register of authorised products.

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0–9
← All medicines · 9 products held by Ascendis Pharma Endocrinology Division A/S
MedicineActive substanceLicence holderStatus
Skytrofa 11 mg Powder and solvent for solution for injection
EU/1/21/1607/008
 Lonapegsomatropin, Somatropin Ascendis Pharma Endocrinology Division A/S —
Skytrofa 13.3 mg Powder and solvent for solution for injection
EU/1/21/1607/009
 Lonapegsomatropin, Somatropin Ascendis Pharma Endocrinology Division A/S —
Skytrofa 3 mg Powder and solvent for solution for injection
EU/1/21/1607/001
 Lonapegsomatropin, Somatropin Ascendis Pharma Endocrinology Division A/S —
Skytrofa 3.6 mg Powder and solvent for solution for injection
EU/1/21/1607/002
 Lonapegsomatropin, Somatropin Ascendis Pharma Endocrinology Division A/S —
Skytrofa 4.3 mg Powder and solvent for solution for injection
EU/1/21/1607/003
 Lonapegsomatropin, Somatropin Ascendis Pharma Endocrinology Division A/S —
Skytrofa 5.2 mg Powder and solvent for solution for injection
EU/1/21/1607/004
 Lonapegsomatropin, Somatropin Ascendis Pharma Endocrinology Division A/S —
Skytrofa 6.3 mg Powder and solvent for solution for injection
EU/1/21/1607/005
 Lonapegsomatropin, Somatropin Ascendis Pharma Endocrinology Division A/S —
Skytrofa 7.6 mg Powder and solvent for solution for injection
EU/1/21/1607/006
 Lonapegsomatropin, Somatropin Ascendis Pharma Endocrinology Division A/S —
Skytrofa 9.1 mg Powder and solvent for solution for injection
EU/1/21/1607/007
 Lonapegsomatropin, Somatropin Ascendis Pharma Endocrinology Division A/S —
Cite this database

Priya Life Science (2026). Irish Medicines Database. Available at: https://priyalifescience.com/medicines (Accessed: 14 August 2026).

Data: Health Products Regulatory Authority (HPRA) open dataset (“Authorised or Transfer Pending Products”), licensed CC BY 4.0, refreshed daily. Regulatory information only — not medical advice.